News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medicago, Inc. and CELLECTIS SA Successfully Achieve First Step in Research Collaboration


10/4/2012 9:39:36 AM

QUEBEC CITY & SAINT PAUL, Minn.--(BUSINESS WIRE)--Regulatory News: Medicago Inc. (TSX: MDG; OTCQX: MDCGF), (“Medicago”) a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles (“VLP”s), and Cellectis plant sciences, a US-based subsidiary of Cellectis Group (Alternext: ALCLS), (“Cellectis”), the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES